EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Nyxoah's enterprise value is €241.95 Mil.
Nyxoah's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €5.13 Mil. Therefore, Nyxoah's EV-to-Revenue for today is 47.18.
The historical rank and industry rank for Nyxoah's EV-to-Revenue or its related term are showing as below:
FRA:5YI'
s EV-to-Revenue Range Over the Past 10 Years
Min: 10.32 Med: 46.97 Max: 2577.46
Current: 47.19
During the past 7 years, the highest EV-to-Revenue of Nyxoah was 2577.46. The lowest was 10.32. And the median was 46.97.
FRA:5YI's EV-to-Revenue is ranked worse than 93.7% of 825
companies
in the Medical Devices & Instruments industry
Industry Median: 3.06
vs FRA:5YI: 47.19
As of today (2024-06-19), Nyxoah's stock price is €7.58.
Nyxoah's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.18. Therefore, Nyxoah's PS Ratio for today is 42.11.
Nyxoah EV-to-Revenue Historical Data
The historical data trend for Nyxoah's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Nyxoah's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nyxoah's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nyxoah's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Nyxoah's EV-to-Revenue falls into.
Nyxoah's current Enterprise Value is €241.95 Mil.
Nyxoah's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.13 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nyxoah's share price for today is €7.58.
Nyxoah's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.18.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nyxoah EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Nyxoah's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:5YI has been successfully added to your 